Table 2 The standardized mortality ratios and hazard ratios in different groups in controls and exposed subjects
Area | Urinary findings | Groups | N | PY | PY/person | D | SMR | (95% CI) | Hazard ratio | (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|
Men | ||||||||||
Control | Pro(-) and Glu(-) | No finding | 748 | 12514 | 16.7 | 441 | 0.88 | (0.80, 0.96) | 1.00 | |
Pro(+) and/or Glu(+) | With findings | 178 | 2608 | 14.7 | 118 | 1.24 | (1.01, 1.46) | 1.39 | (1.13, 1.70)** | |
Exposed | Pro(-) and Glu(-) | No finding | 2556 | 44636 | 17.5 | 1595 | 0.90 | (0.85, 0.94) | 1.02 | (0.92, 1.14) |
Pro(-) and Glu(+) | Glucoseuria | 498 | 8444 | 17.0 | 331 | 0.96 | (0.86, 1.07) | 1.10 | (0.95, 1.27) | |
Pro(+) and Glu(-) | Proteinuria | 150 | 1905 | 12.7 | 123 | 1.19 | (0.98, 1.40) | 1.27 | (1.03, 1.57)* | |
Pro(+) and Glu(+) | Glucoproteinuria | 159 | 1579 | 9.9 | 147 | 1.40 | (1.17, 1.63) | 1.57 | (1.29, 1.90)*** | |
Women | ||||||||||
Control | Pro(-) and Glu(-) | No finding | 1039 | 19085 | 18.4 | 455 | 0.89 | (0.81, 0.97) | 1.00 | |
Pro(+) and/or Glu(+) | with findings | 133 | 1884 | 14.2 | 77 | 1.16 | (0.90, 1.41) | 1.26 | (0.99, 1.61) | |
Exposed | Pro(-) and Glu(-) | No finding | 3184 | 64520 | 20.3 | 1405 | 0.84 | (0.90, 0.88) | 0.93 | (0.83, 1.03) |
Pro(-) and Glu(+) | Glucoseuria | 398 | 6568 | 16.5 | 278 | 1.27 | (1.12, 1.41) | 1.40 | (1.20, 1.63)*** | |
Pro(+) and Glu(-) | Proteinuria | 136 | 1947 | 14.3 | 106 | 1.44 | (1.16, 1.71) | 1.77 | (1.42, 2.20)*** | |
Pro(+) and Glu(+) | Glucoproteinuria | 267 | 2406 | 9.0 | 257 | 2.02 | (1.77, 2.26) | 2.40 | (2.16, 2.80)*** | |